Steketee RW, Nahlen BL, Parise ME, Menendez C, 2001. The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg 64 :28–35.
Guyatt HL, Snow RW, 2001. The epidemiology and burden of Plasmodium falciparum-related anemia among pregnant women in sub-Saharan Africa. Am J Trop Med Hyg 64 (Suppl):36–44.
Guyatt HL, Snow RW, 2004. Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa. Clin Microbiol Rev 17 :760–769.
Gamble C, Ekwaru JP, ter Kuile FO, 2006. Insecticide-treated nets for preventing malaria in pregnancy. Cochrane Database Syst Rev: CD003755.
Schultz LJ, Steketee RW, Macheso A, Kazembe P, Chitsulo L, Wirima JJ, 1994. The efficacy of antimalarial regimens containing sulfadoxine-pyrimethamine and/or chloroquine in preventing peripheral and placental Plasmodium falciparum infection among pregnant women in Malawi. Am J Trop Med Hyg 51 :515–522.
Verhoeff FH, Brabin BJ, Chimsuku L, Kazembe P, Russell WB, Broadhead RL, 1998. An evaluation of the effects of intermittent sulfadoxine-pyrimethamine treatment in pregnancy on parasite clearance and risk of low birthweight in rural Malawi. Ann Trop Med Parasitol 92 :141–150.
Parise ME, Ayisi JG, Nahlen BL, Schultz LJ, Roberts JM, Misore A, Muga R, Oloo AJ, Steketee RW, 1998. Efficacy of sufadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg 59 :813–822.
Shulman CE, Dorman EK, Cutts F, Kawuondo K, Bulmer JN, Peshu N, Marsh K, 1999. Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial. Lancet 353 :632–636.
Kayentao K, Kodio M, Newman RD, Maiga H, Doumtabe D, Ongoiba A, Coulibaly D, Keita AS, Maiga B, Mungai M, Parise ME, Doumbo O, 2005. Comparison of intermittent preventive treatment with chemoprophylaxis for the prevention of malaria during pregnancy in Mali. J Infect Dis 191 :109–116.
Rogerson SJ, Chaluluka E, Kanjala M, Mkundika P, Mhango CG, Molyneux ME, 2000. Intermittent sulphadoxine-pyrimethamine in pregnancy: effectiveness against malaria morbidity in Blantyre, Malawi 1997–1999. Trans R Soc Trop Med Hyg 94 :549–553.
Holtz TH, Kachur SP, Roberts JM, Marum LH, Mkandala C, Chizani N, Macheso A, Parise ME, 2004. Use of antenatal care services and intermittent preventive treatment for malaria among pregnant women in Blantyre District, Malawi. Trop Med Int Health 9 :77–82.
van Eijk AM, Ayisi JG, ter Kuile FO, Slutsker L, Otieno JA, Misore AO, Odondi JO, Rosen DH, Kager PA, Steketee RW, Nahlen BL, 2004. Implementation of intermittent preventive treatment with sulphadoxine-pyrimethamine for control of malaria in pregnancy in Kisumu, western Kenya. Trop Med Int Health 9 :630–637.
van Eijk AM, Bles HM, Odhiambo F, Ayisi JG, Blokland IE, Rosen DH, Adazu K, Slutsker L, Lindblade KA, 2006. Use of antenatal services and delivery care among women in rural western Kenya: a community based survey. Reprod Health 3 :2.
Brabin BJ, 1983. An analysis of malaria in pregnancy in Africa. Bull WHO 61 :1005–1016.
Lindsay S, Ansell J, Selman C, Cox V, Hamilton K, Walraven G, 2000. Effect of pregnancy on exposure to malaria mosquitoes. Lancet 355 :1972.
Walker-Abbey A, Djokam RR, Eno A, Leke RF, Titanji VP, Fogako J, Sama G, Thuita LH, Beardslee E, Snounou G, Zhou A, Taylor DW, 2005. Malaria in pregnant Cameroonian women: the effect of age and gravidity on submicroscopic and mixed-species infections and multiple parasite genotypes. Am J Trop Med Hyg 72 :229–235.
Saute F, Menendez C, Mayor A, Aponte J, Gomez-Olive X, Dgedge M, Alonso P, 2002. Malaria in pregnancy in rural Mozambique: the role of parity, submicroscopic and multiple Plasmodium falciparum infections. Trop Med Int Health 7 :19–28.
Schleiermacher D, Rogier C, Spiegel A, Tall A, Trape JF, Mercereau-Puijalon O, 2001. Increased multiplicity of Plasmodium falciparum infections and skewed distribution of individual msp1 and msp2 alleles during pregnancy in Ndiop, a Senegalese village with seasonal, mesoendemic malaria. Am J Trop Med Hyg 64 :303–309.
Brabin BJ, Rogerson SJ, 2001. The epidemiology and outcomes of maternal malaria. Duffy PE, Fried M, eds. Malaria in Pregnancy Deadly Parasite, Susceptible Host. London and New York: Taylor and Francis, 27–52.
Rogerson SJ, van den Broek NR, Chaluluka E, Qonqwane C, Mhango CG, Molyneux ME, 2000. Malaria and anemia in antenatal women in Blantyre, Malawi: a twelve month survey. Am J Trop Med Hyg 62 :335–340.
Dicko A, Mantel C, Thera MA, Doumbia S, Diallo M, Diakite M, Sagara I, Doumbo OK, 2003. Risk factors for malaria infection and anemia for pregnant women in the Sahel area of Bandiagara, Mali. Acta Trop 89 :17–23.
Trape JF, Rogier C, 1996. Combating malaria morbidity and mortality by reducing transmission. Parasitol Today 12 :236–240.
ter Kuile FO, Parise ME, Verhoeff FH, Udhayakumar V, Newman RD, van Eijk AM, Rogerson SJ, Steketee RW, 2004. The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa. Am J Trop Med Hyg 71 :41–54.
Nosten F, Rogerson SJ, Beeson JG, McGready R, Mutabingwa TK, Brabin B, 2004. Malaria in pregnancy and the endemicity spectrum: what can we learn? Trends Parasitol 20 :425–432.
Duffy PE, Fried M, 2005. Malaria in the pregnant woman. Curr Top Microbiol Immunol 295 :169–200.
Nosten F, McGready R, Simpson JA, Thwai KL, Balkan S, Cho T, Hkirijaroen L, Looareesuwan S, White NJ, 1999. Effects of Plasmodium vivax malaria in pregnancy. Lancet 354 :546–549.
Singh N, Shukla MM, Sharma VP, 1999. Epidemiology of malaria in pregnancy in central India. Bull WHO 77 :567–572.
Diagne N, Rogier C, Sokhna CS, Tall A, Fontenille D, Roussilhon C, Spiegel A, Trape JF, 2000. Increased susceptibility to malaria during the early postpartum period. N Engl J Med 343 :598–603.
Duraisingh MT, Voss TS, Marty AJ, Duffy MF, Good RT, Thompson JK, Freitas-Junior LH, Scherf A, Crabb BS, Cowman AF, 2005. Heterochromatin silencing and locus repositioning linked to regulation of virulence genes in Plasmodium falciparum. Cell 121 :13–24.
Brabin BJ, Romagosa C, Abdelgalil S, Menendez C, Verhoeff FH, McGready R, Fletcher KA, Owens S, D’Alessandro U, Nosten F, Fischer PR, Ordi J, 2004. The sick placenta—the role of malaria. Placenta 25 :359–378.
Menendez C, Ordi J, Ismail MR, Ventura PJ, Aponte JJ, Kahigwa E, Font F, Alonso PL, 2000. The impact of placental malaria on gestational age and birth weight. J Infect Dis 181 :1740–1745.
Jilly P, 1969. Anaemia in parturient women, with special reference to malaria infection of the placenta. Ann Trop Med Parasitol 63 :109–116.
Watkinson M, Rushton DI, 1983. Plasmodial pigmentation of placenta and outcome of pregnancy in West African mothers. Br Med J 287 :251–254.
Leopardi O, Naughten W, Salvia L, Colecchia M, Matteelli A, Zucchi A, Shein A, Muchi JA, Carosi G, Ghione M, 1996. Malaric placentas. A quantitative study and clinico-pathological correlations. Pathol Res Pract 192 :892–898.
Ordi J, Ismail MR, Ventura P, Kahigwa E, Hirt R, Cardesa A, Alonso P, Menendez C, 1998. Massive chronic intervillositis of the placenta associated with malarial infection. Am J Surg Pathol 22 :1006–1011.
Rogerson SJ, Pollina E, Getachew A, Tadesse E, Lema VM, Molyneux ME, 2003. Placental monocyte infiltrates in response to Plasmodium falciparum infection and their association with adverse pregnancy outcomes. Am J Trop Med Hyg 68 :115–119.
Rogerson SJ, Mkundika P, Kanjala MK, 2003. Diagnosis of Plasmodium falciparum malaria at delivery: comparison of blood film preparation methods and of blood films with histology. J Clin Microbiol 41 :1370–1374.
Sullivan AD, Nyirenda T, Cullinan T, Taylor T, Lau A, Meshnick SR, 2000. Placental haemozoin and malaria in pregnancy. Placenta 21 :417–421.
McGready R, Davison BB, Stepniewska K, Cho T, Shee H, Brockman A, Udomsangpetch R, Looareesuwan S, White NJ, Meshnick SR, Nosten F, 2004. The effects of Plasmodium falciparum and P. vivax infections on placental histopathology in an area of low malaria transmission. Am J Trop Med Hyg 70 :398–407.
Turner GDH, Morrison H, Jones M, Davis TME, Looareesuwan S, Buley ID, Gatter KC, Newbold CI, Pukritayakamee S, Nagachinta B, White NJ, Berendt AR, 1994. An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. Am J Pathol 145 :1057–1069.
Grau GE, Mackenzie CD, Carr RA, Redard M, Pizzolato G, Allasia C, Cataldo C, Taylor TE, Molyneux ME, 2003. Platelet accumulation in brain microvessels in fatal pediatric cerebral malaria. J Infect Dis 187 :461–466.
Fried M, Duffy PE, 1996. Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta. Science 272 :1502–1504.
Beeson JG, Rogerson SJ, Cooke BM, Reeder JC, Chai W, Lawson AM, Molyneux ME, Brown GV, 2000. Adhesion of Plasmodium falciparum-infected erythrocytes to hyaluronic acid in placental malaria. Nat Med 6 :86–90.
Salem HH, Maruyama I, Ishii H, Majerus PW, 1984. Isolation and characterization of thrombomodulin from human placenta. J Biol Chem 259 :12246–12251.
Matejevic D, Neudeck H, Graf R, Muller T, Dietl J, 2001. Localization of hyaluronan with a hyaluronan-specific hyaluronic acid binding protein in the placenta in pre-eclampsia. Gynecol Obstet Invest 52 :257–259.
Walter PR, Garin Y, Blot P, 1982. Placental pathologic changes in malaria. A histologic and ultrastructural study. Am J Pathol 109 :330–342.
Muthusamy A, Achur RN, Bhavanandan VP, Fouda GG, Taylor DW, Gowda DC, 2004. Plasmodium falciparum-infected erythrocytes adhere both in the intervillous space and on the villous surface of human placenta by binding to the low-sulfated chondroitin sulfate proteoglycan receptor. Am J Pathol 164 :2013–2025.
Imamura T, Sugiyama T, Cuevas LE, Makunde R, Nakamura S, 2002. Expression of tissue factor, the clotting initiator, on macrophages in Plasmodium falciparum-infected placentas. J Infect Dis 186 :436–440.
Carlson J, Helmby H, Hill AVS, Brewster D, Greenwood BM, Wahlgren M, 1990. Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet 336 :1457–1460.
Maubert B, Fievet N, Tami G, Boudin C, Deloron P, 1998. Plasmodium falciparum—isolates from Cameroonian pregnant women do not rosette. Parasite 5 :281–283.
Rogerson SJ, Beeson JG, Mhango C, Dzinjalamala F, Molyneux ME, 2000. Plasmodium falciparum rosette formation is uncommon in isolates from pregnant women. Infect Immun 68 :391–393.
Creasey AM, Staalsoe T, Raza A, Arnot DE, Rowe JA, 2003. Nonspecific immunoglobulin M binding and chondroitin sulfate A binding are linked phenotypes of Plasmodium falciparum isolates implicated in malaria during pregnancy. Infect Immun 71 :4767–4771.
Ismail MR, Ordi J, Menendez C, Ventura PJ, Aponte JJ, Kahigwa E, Hirt R, Cardesa A, Alonso PL, 2000. Placental pathology in malaria: a histological, immunohistochemical, and quantitative study. Hum Pathol 31 :85–93.
Fried M, Nosten F, Brockman A, Brabin BJ, Duffy PE, 1998. Maternal antibodies block malaria. Nature 395 :851–852.
Ricke CH, Staalsoe T, Koram K, Akanmori BD, Riley EM, Theander TG, Hviid L, 2000. Plasma antibodies from malaria-exposed pregnant women recognize variant surface antigens on Plasmodium falciparum-infected erythrocytes in a parity-dependent manner and block parasite adhesion to chondroitin sulfate A. J Immunol 165 :3309–3316.
Duffy PE, Fried M, 2003. Antibodies that inhibit Plasmodium falciparum adhesion to chondroitin sulfate A are associated with increased birth weight and the gestational age of newborns. Infect Immun 71 :6620–6623.
Staalsoe T, Shulman CE, Bulmer JN, Kawuondo K, Marsh K, Hviid L, 2004. Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria. Lancet 363 :283–289.
Baruch DI, Gormley JA, Ma C, Howard RJ, Pasloske BL, 1996. Plasmodium falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and intercellular adhesion molecule 1. Proc Natl Acad Sci U S A 93 :3497–3502.
Smith JD, Chitnis CE, Craig AG, Roberts DJ, Hudson-Taylor DE, Peterson DS, Pinches R, Newbold CI, Miller LH, 1995. Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes. Cell 82 :101–110.
Newbold CI, Pinches R, Roberts DJ, Marsh K, 1992. Plasmodium falciparum: the human agglutinating antibody response to the infected red cell surface is predominantly variant specific. Exp Parasitol 75 :281–292.
Rowe JA, Kyes SA, 2004. The role of Plasmodium falciparum var genes in malaria in pregnancy. Mol Microbiol 53 :1011–1019.
Salanti A, Staalsoe T, Lavstsen T, Jensen AT, Sowa MP, Arnot DE, Hviid L, Theander TG, 2003. Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria. Mol Microbiol 49 :179–191.
Duffy MF, Byrne TJ, Elliott SR, Wilson D, Rogerson SJ, Beeson JG, Noviyanti R, Brown GV, 2005. Broad analysis reveals a consistent pattern of var gene transcription in Plasmodium falciparum repeatedly selected for a defined adhesion phenotype. Mol Microbiol 56 :774–788.
Viebig NK, Gamain B, Scheidig C, Lepolard C, Przyborski J, Lanzer M, Gysin J, Scherf A, 2005. A single member of the Plasmodium falciparum var multigene family determines cytoadhesion to the placental receptor chondroitin sulphate A. EMBO Rep 6 :775–781.
Duffy MF, Maier AG, Byrne TJ, Marty AJ, Elliott SR, O’Neill MT, Payne PD, Rogerson SJ, Cowman AF, Crabb BS, Brown GV, 2006. VAR2CSA is the principal ligand for chondroitin sulfate A in two allogeneic isolates of Plasmodium falciparum. Mol Biochem Parasitol 148 :117–124.
Tuikue Ndam NG, Salanti A, Bertin G, Dahlback M, Fievet N, Turner L, Gaye A, Theander T, Deloron P, 2005. High level of var2csa transcription by Plasmodium falciparum isolated from the placenta. J Infect Dis 192 :331–335.
Duffy MF, Caragounis A, Noviyanti R, Kyriacou HM, Choong EK, Boysen K, Healer J, Rowe JA, Molyneux ME, Brown GV, Rogerson SJ, 2006. Transcribed var genes associated with placental malaria in Malawian women. Infect Immun 74 :4875–4883.
Gamain B, Trimnell AR, Scheidig C, Scherf A, Miller LH, Smith JD, 2005. Identification of multiple chondroitin sulfate A (CSA)-binding domains in the var2CSA gene transcribed in CSA-binding parasites. J Infect Dis 191 :1010–1013.
Salanti A, Dahlback M, Turner L, Nielsen MA, Barfod L, Magistrado P, Jensen AT, Lavstsen T, Ofori MF, Marsh K, Hviid L, Theander TG, 2004. Evidence for the involvement of VAR2CSA in pregnancy-associated malaria. J Exp Med 200 :1197–1203.
Tuikue Ndam NG, Salanti A, Le-Hesran JY, Cottrell G, Fievet N, Turner L, Sow S, Dangou JM, Theander T, Deloron P, 2006. Dynamics of anti-VAR2CSA immunoglobulin G response in a cohort of senegalese pregnant women. J Infect Dis 193 :713–720.
Trimnell AR, Kraemer SM, Mukherjee S, Phippard DJ, Janes JH, Flamoe E, Su XZ, Awadalla P, Smith JD, 2006. Global genetic diversity and evolution of var genes associated with placental and severe childhood malaria. Mol Biochem Parasitol 148 :169–180.
Beeson JG, Mann EJ, Byrne TJ, Caragounis A, Elliott SR, Brown GV, Rogerson SJ, 2006. Antigenic differences and conservation among placental type Plasmodium falciparum-infected erythrocytes and acquisition of variant-specific and cross-reactive antibodies. J Infect Dis 193 :721–730.
Fried M, Wendler JP, Mutabingwa TK, Duffy PE, 2004. Mass spectrometric analysis of Plasmodium falciparum erythrocyte membrane protein-1 variants expressed by placental malaria parasites. Proteomics 4 :1086–1093.
Flick K, Scholander C, Chen Q, Fernandez V, Pouvelle B, Gysin J, Wahlgren M, 2001. Role of nonimmune IgG bound to PfEMP1 in placental malaria. Science 293 :2098–2100.
Rasti N, Namusoke F, Chene A, Chen Q, Staalsoe T, Klinkert M-Q, Mirembe F, Kironde F, Wahlgren M, 2006. Nonimmune immunoglobulin binding and multiple adhesion characterize Plasmodium falciparum-infected erythrocytes of placental origin 10.1073/pnas.0601519103. Proc Natl Acad Sci U S A 103 :13795–13800.
Raghupathy R, 1997. Th 1-type immunity is incompatible with successful pregnancy. Immunol Today 18 :478–482.
Fried M, Muga RO, Misore AO, Duffy PE, 1998. Malaria elicits type 1 cytokines in the human placenta: IFN-γ and TNF-α associated with pregnancy outcomes. J Immunol 160 :2523–2530.
Moore J, Nahlen B, Misore A, Lal A, Udhayakumar V, 1999. Immunity to placental malaria. I. Elevated production of interferon-gamma by placental blood mononuclear cells is associated with protection in an area with high transmission of malaria. J Infect Dis 179 :1218–1225.
Moormann AM, Sullivan AD, Rochford RA, Chensue SW, Bock PJ, Nyirenda T, Meshnick SR, 1999. Malaria and pregnancy: placental cytokine expression and its relationship to intrauterine growth retardation. J Infect Dis 180 :1987–1993.
Rogerson SJ, Brown HC, Pollina E, Abrams ET, Tadesse E, Lema VM, Molyneux ME, 2003. Placental tumor necrosis factor alpha but not gamma interferon is associated with placental malaria and low birth weight in Malawian women. Infect Immun 71 :267–270.
Abrams ET, Milner D, Kwiek J, Mwapasa V, Kamwendo DD, Tadesse E, Lema VM, Molyneux ME, Rogerson SJ, Meshnick SR, 2004. Risk factors and mechanisms of preterm delivery in Malawi. Am J Reprod Immunol 52 :174–183.
Ordi J, Menendez C, Ismail MR, Ventura PJ, Palacin A, Kahigwa E, Ferrer B, Cardesa A, Alonso PL, 2001. Placental malaria is associated with cell-mediated inflammatory responses with selective absence of natural killer cells. J Infect Dis 183 :1100–1107.
Hviid L, Theander TG, Abdulhadi NH, Abu ZY, Bayoumi RA, Jensen JB, 1991. Transient depletion of T cells with high LFA-1 expression from peripheral circulation during acute Plasmodium falciparum malaria. Eur J Immunol 21 :1249–1253.
Malkin E, Dubovsky F, Moree M, 2006. Progress towards the development of malaria vaccine. Trends Parasitol 22 :292–295.
Alonso PL, Sacarlal J, Aponte JJ, Leach A, Macete E, Milman J, Mandomando I, Spiessens B, Guinovart C, Espasa M, Bassat Q, Aide P, Ofori-Anyinam O, Navia MM, Corachan S, Ceuppens M, Dubois MC, Demoitie MA, Dubovsky F, Menendez C, Tornieporth N, Ballou WR, Thompson R, Cohen J, 2004. Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet 364 :1411–1420.
Bojang KA, Milligan PJM, Pinder M, Vigneron L, Alloueche A, Kester KE, Ballou WR, Conway DJ, Reece WHH, Gothard P, Yamuah L, Delchambre M, Voss G, Greenwood BM, Hill A, McAdam KPWJ, Tornieporth N, Cohen JD, Doherty T, 2001. Efficacy of TSF,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet 358 :1927–1934.
Ayisi JG, Branch OH, Rafi-Janajreh A, van Eijk AM, ter Kuile FO, Rosen DH, Kager PA, Lanar DE, Barbosa A, Kaslow D, Nahlen BL, Lal AA, 2003. Does infection with human immunodeficiency virus affect the antibody responses to Plasmodium falciparum antigenic determinants in asymptomatic pregnant women? J Infect 46 :164–172.
Mount AM, Mwapasa V, Elliott SR, Beeson JG, Tadesse E, Lema VM, Molyneux ME, Meshnick SR, Rogerson SJ, 2004. HIV infection impairs humoral immunity to Plasmodium falciparum malaria in pregnancy. Lancet 363 :1860–1867.
Taylor DW, Zhou A, Marsillio LE, Thuita LW, Leke EB, Branch O, Gowda DC, Long C, Leke RF, 2004. Antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A and to the C terminus of merozoite surface protein 1 correlate with reduced placental malaria in Cameroonian women. Infect Immun 72 :1603–1607.
Greenwood AM, Menendez C, Alonso PL, Jaffar S, Langerock P, Lulat S, Todd J, Mboge B, Francis N, Greenwood BM, 1994. Can malaria chemoprophylaxis be restricted to first pregnancies? Trans R Soc Trop Med Hyg 88 :681–682.
Staalsoe T, Shulman CE, Dorman EK, Kawuondo K, Marsh K, Hviid L, 2004. Intermittent preventive sulfadoxine-pyrimethamine treatment of primigravidae reduces levels of plasma immunoglobulin G, which protects against pregnancy-associated Plasmodium falciparum malaria. Infect Immun 72 :5027–5030.
Kariuki SK, ter Kuile FO, Wannemuehler K, Terlouw DJ, Kolczak MS, Hawley WA, Phillips-Howard PA, Orago AS, Nahlen BL, Lal AA, Shi YP, 2003. Effects of permethrin-treated bed nets on immunity to malaria in western Kenya I. Antibody responses in pregnant women and cord blood in an area of intense malaria transmission. Am J Trop Med Hyg 68 :61–67.
WHO, 2004. A Strategic Framework for Malaria Prevention and Control During Pregnancy in the African Region. Brazzaville: World Health Organization Regional Office for Africa.
Hill J, Kazembe P, 2006. Reaching the Abuja target for intermittent preventive treatment of malaria in pregnancy in African women: a review of progress and operational challenges. Trop Med Int Health 11 :409–418.
Brabin BJ, 1991. The Risks and Severity of Malaria in Pregnant Women. Applied Field Research in Malaria. Geneva: WHO, 1–34.
Jauniaux E, Gulbis B, Burton GJ, 2003. The human first trimester gestational sac limits rather than facilitates oxygen transfer to the foetus—a review. Placenta 24 :S86–S93.
Bouyou-Akotet MK, Adegnika AA, Agnandji ST, Ngou-Milama E, Kombila M, Kremsner PG, Mavoungou E, 2005. Cortisol and susceptibility to malaria during pregnancy. Microbes Infect 7 :1217–1223.
Vleugels MP, Eling WM, Rolland R, de Graaf R, 1987. Cortisol and loss of malaria immunity in human pregnancy. Br J Obstet Gynaecol 94 :758–764.
Watkinson M, Rushton DI, Lunn PG, 1985. Placental malaria and foetoplacental function: low plasma oestradiols associated with malarial pigmentation of the placenta. Trans R Soc Trop Med Hyg 79 :448–450.
Lala PK, Chakraborty C, 2003. Factors regulating trophoblast migration and invasiveness: possible derangements contributing to pre-eclampsia and fetal injury (1). Placenta 24 :575–587.
Bauer S, Pollheimer J, Hartmann J, Husslein P, Aplin JD, Knofler M, 2004. Tumor necrosis factor-alpha inhibits trophoblast migration through elevation of plasminogen activator inhibitor-1 in first-trimester villous explant cultures. J Clin Endocrinol Metab 89 :812–822.
Redman CW, Sargent IL, 2005. Latest advances in understanding preeclampsia. Science 308 :1592–1594.
Dorman EK, Shulman CE, Kingdom J, Bulmer JN, Mwendwa J, Peshu N, Marsh K, 2002. Impaired uteroplacental blood flow in pregnancies complicated by falciparum malaria. Ultrasound Obstet Gynecol 19 :165–170.
White NJ, 2005. Intermittent presumptive treatment for malaria. PLoS Med. 2 :e3.
Silverman WA, Andersen DH, Blanc WA, Crozier DN, 1956. A difference in mortality rate and incidence of kernicterus among premature infants allotted to two prophylactic regimens. Pediatrics 18 :614–625.
Ramharter M, Grobusch MP, Kiessling G, Adegnika AA, Moller U, Agnandji ST, Kramer M, Schwarz N, Kun JF, Oyakhirome S, Issifou S, Borrmann S, Lell B, Mordmuller B, Kremsner PG, 2005. Clinical and parasitological characteristics of puerperal malaria. J Infect Dis 191 :1005–1009.
Lema VM, Changole J, Kanyighe C, Malunga EV, 2005. Maternal mortality at the Queen Elizabeth Central Teaching Hospital, Blantyre, Malawi. East Afr Med J 82 :3–9.
Rayco-Solon P, Fulford AJ, Prentice AM, 2005. Differential effects of seasonality on preterm birth and intrauterine growth restriction in rural Africans. Am J Clin Nutr 81 :134–139.
Mitchell D, 1979. Accuracy of pre- and postnatal assessment of gestational age. Arch Dis Child 54 :896–904.
Goldenberg RL, Cutter GR, Hoffman HJ, Foster JM, Nelson KG, Hauth JC, 1989. Intrauterine growth retardation: standards for diagnosis. Am J Obstet Gynecol 161 :271–277.
Ceesay SM, Prentice AM, Cole TJ, Foord F, Weaver LT, Poskitt EM, Whitehead RG, 1997. Effects on birth weight and perinatal mortality of maternal dietary supplements in rural Gambia: 5 year randomised controlled trial. BMJ 315 :786–790.
van den Broek NR, Letsky EA, 2000. Etiology of anemia in pregnancy in south Malawi. Am J Clin Nutr 72 :247S–256S.
van den Broek N, 2001. Anaemia in pregnancy in sub-Saharan countries. Eur J Obstet Gynecol Reprod Biol 96 :4–6.
Wagner G, Koram K, McGuinness D, Bennett S, Nkrumah F, Riley EM, 1998. High incidence of asymptomatic malaria infections in a birth cohort of children less than one year of age in Ghana, detected by multicopy gene polymerase chain reaction. Am J Trop Med Hyg 59 :115–123.
Riley EM, Wagner GE, Akanmori BD, Koram KA, 2001. Do maternally acquired antibodies protect infants from malaria infection? Parasite Immunol 23 :51–59.
Tobian AAR, Mehlotra RK, Malhotra I, Wamachi A, Mungai P, Koech D, Ouma J, Zimmerman P, King CL, 2000. Frequent umbilical cord-blood and maternal-blood infections with Plasmodium falciparum, P. malariae and P. ovale in Kenya. J Infect Dis 182 :558–563.
Kamwendo DD, Dzinjalamala FK, Snounou G, Kanjala MCC, Mhango CG, Molyneux ME, Rogerson SJ, 2002. Plasmodium falciparum: PCR detection and genotyping of isolates from peripheral, placental, and cord blood of pregnant Malawian women and their infants. Trans R Soc Trop Med Hyg 96 :145–149.
Fischer PR, 2003. Malaria and newborns. J Trop Pediatr 49 :132–134.
Branch O, Udhayakumar V, Hightower A, Oloo A, Hawley W, Nahlen B, Bloland P, Kaslow D, Lal A, 1998. A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-119-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrileillness, parasitemia, and anemia. Am J Trop Med Hyg 58 :211–219.
Hviid L, Staalsoe T, 2004. Malaria immunity in infants: a special case of a general phenomenon? Trends Parasitol 20 :66–72.
Malhotra I, Mungai P, Muchiri E, Ouma J, Sharma S, Kazura JW, King CL, 2005. Distinct Th1- and Th2-Type prenatal cytokine responses to Plasmodium falciparum erythrocyte invasion ligands. Infect Immun 73 :3462–3470.
King CL, Malhotra I, Wamachi A, Kioko J, Mungai P, Wahab SA, Koech D, Zimmerman P, Ouma J, Kazura JW, 2002. Acquired immune responses to Plasmodium falciparum merozoite surface protein-1 in the human fetus. J Immunol 168 :356–364.
Hulbert TV, 1992. Congenital malaria in the United States: report of a case and review. Clin Infect Dis 14 :922–926.
de Moraes-Pinto MI, Almeida ACM, Kenj G, Filgueiras TE, Tobias W, Santos AMN, Carneiro-Sampaio MMS, Farhat CK, Milligan PJM, Johnson PM, Hart CA, 1996. Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection. J Infect Dis 173 :1077–1084.
de Moraes-Pinto MI, Verhoeff F, Chimsuku L, Milligan PJ, Wesumperuma L, Broadhead RL, Brabin BJ, Johnson PM, Hart CA, 1998. Placental antibody transfer: influence of maternal HIV infection and placental malaria. Arch Dis Child Fetal Neonatal Ed 79 :F202–F205.
Newman RD, Parise ME, Slutsker L, Nahlen B, Steketee RW, 2003. Safety, efficacy and determinants of effectiveness of antimalarial drugs during pregnancy: implications for prevention programmes in Plasmodium falciparum-endemic sub-Saharan Africa. Trop Med Int Health 8 :488–506.
Nosten F, McGready R, d’Alessandro U, Bonell A, Verhoeff F, Menendez C., Mutabingwa T, Brabin B, 2006. Antimalarial drugs in pregnancy: a review. Current Drug Safety 1 :1–15.
Rogerson SJ, Menendez C, 2006. Treatment and prevention of malaria in pregnancy: opportunities and challenges. Expert Rev Anti Infect Ther 4 :687–702.
Na Bangchang K, Davis TM, Looareesuwan S, White NJ, Bunnag D, Karbwang J, 1994. Mefloquine pharmacokinetics in pregnant women with acute falciparum malaria. Trans R Soc Trop Med Hyg 88 :321–323.
McGready R, Stepniewska K, Edstein MD, Cho T, Gilveray G, Looareesuwan S, White NJ, Nosten F, 2003. The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria. Eur J Clin Pharmacol 59 :545–552.
McGready R, Stepniewska K, Ward SA, Cho T, Gilveray G, Looareesuwan S, White NJ, Nosten F, 2006. Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria. Eur J Clin Pharmacol 62 :367–371.
Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, Mukadam RAG, Rogerson SJ, Lescano AG, Molyneux ME, Winstanley PA, Ghimpeni P, Taylor TE, Plowe CV, 2002. Molecular markers for treatment failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone for falciparum malaria and a model for practical application in Africa. J Infect Dis 185 :380–388.
Alker AP, Mwapasa V, Purfield A, Rogerson SJ, Molyneux ME, Kamwendo DD, Tadesse E, Chaluluka E, Meshnick SR, 2005. Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi. Antimicrob Agents Chemother 49 :3919–3921.
Hurwitz ES, Johnson D, Campbell CC, 1981. Resistance of Plasmodium falciparum malaria to sulfadoxine-pyrimethamine (’Fansidar’) in a refugee camp in Thailand. Lancet 1 :1068–1070.
Simooya O, 2005. The WHO ’Roll Back Malaria Project’: planning for adverse event monitoring in Africa. Drug Saf 28 :277–286.
Kraemer SM, Smith JD, 2003. Evidence for the importance of genetic structuring to the structural and functional specialization of the Plasmodium falciparum var gene family. Mol Microbiol 50 :1527–1538.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 0 | 0 | 0 |
Full Text Views | 340 | 305 | 39 |
PDF Downloads | 60 | 48 | 6 |
Pregnant women are susceptible to malaria during pregnancy. Plasmodium falciparum, which sequesters in the placenta, causes the greatest disease, contributing significantly to maternal and infant mortality. Parasitized cells in the placenta express unique variant surface antigens (VSA), predominantly the VAR2CSA protein, and lack of immunity to these pregnancy-specific variant surface antigens explains some of the pregnancy-associated malaria susceptibility. Changes in acquired cellular immunity during pregnancy also appear important. Placental inflammatory responses, particularly monocyte infiltrates, predispose to fetal growth restriction and maternal anemia. Preventing malaria in pregnancy relies on insecticide treated bed nets, intermittent preventive treatment with antimalarials such as sulphadoxine–pyrimethamine, and potentially relies on the development of effective vaccines. The optimal deployment of each may depend heavily on the relationship between the timing of placental malaria infection and its deleterious consequences. Improved understanding of the relationship between pathogenesis, immunity, and pregnancy outcome will allow better targeting of our interventions to prevent the consequences of malaria in pregnancy.